153 related articles for article (PubMed ID: 10607376)
1. Evaluation of the developmental toxicity of thalidomide using frog embryo teratogenesis assay-xenopus (FETAX): biotransformation and detoxification.
Fort DJ; Stover EL; Bantle JA; Finch RA
Teratog Carcinog Mutagen; 2000; 20(1):35-47. PubMed ID: 10607376
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the developmental toxicity of benzo[a]pyrene and 2-acetylaminofluorene using Xenopus: modes of biotransformation. Stover Group.
Propst TL; Fort DJ; Stover EL; Schrock B; Bantle JA
Drug Chem Toxicol; 1997; 20(1-2):45-61. PubMed ID: 9183562
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the developmental toxicity of 4-bromobenzene using frog embryo teratogenesis assay--Xenopus: possible mechanisms of action.
Fort DJ; Propst TL; Stover EL
Teratog Carcinog Mutagen; 1996; 16(6):307-15. PubMed ID: 9178453
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the developmental toxicities of ethanol, acetaldehyde, and thioacetamide using FETAX.
Fort DJ; McLaughlin DW; Rogers RL; Buzzard BO
Drug Chem Toxicol; 2003 Feb; 26(1):23-34. PubMed ID: 12643038
[TBL] [Abstract][Full Text] [Related]
5. Optimization of an exogenous metabolic activation system for FETAX. I. Post-isolation rat liver microsome mixtures.
Fort DJ; Rogers RL; Stover EL; Finch RA
Drug Chem Toxicol; 2001 May; 24(2):103-15. PubMed ID: 11360429
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of glucose-6-phosphate and NADP against alpha-chaconine-induced developmental toxicity in Xenopus embryos.
Rayburn JR; Bantle JA; Qualls CW; Friedman M
Food Chem Toxicol; 1995 Dec; 33(12):1021-5. PubMed ID: 8846997
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the developmental toxicity of trichloroethylene and detoxification metabolites using Xenopus.
Fort DJ; Stover EL; Rayburn JR; Hull M; Bantle JA
Teratog Carcinog Mutagen; 1993; 13(1):35-45. PubMed ID: 8100651
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the mechanism of isoniazid-induced developmental toxicity with frog embryo teratogenesis assay: Xenopus (FETAX).
Fort DJ; Bantle JA
Teratog Carcinog Mutagen; 1990; 10(6):463-76. PubMed ID: 1982910
[TBL] [Abstract][Full Text] [Related]
9. Use of Frog Embryo Teratogenesis Assay-Xenopus and an exogenous metabolic activation system to evaluate the developmental toxicity of diphenylhydantoin.
Fort DJ; Bantle JA
Fundam Appl Toxicol; 1990 May; 14(4):720-33. PubMed ID: 2361573
[TBL] [Abstract][Full Text] [Related]
10. Assessing the predictive validity of frog embryo teratogenesis assay-Xenopus (FETAX).
Fort DJ; Stover EL; Farmer DR; Lemen JK
Teratog Carcinog Mutagen; 2000; 20(2):87-98. PubMed ID: 10679752
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the developmental toxicity of caffeine and caffeine metabolites using the frog embryo teratogenesis assay--Xenopus (FETAX).
Fort DJ; Stover EL; Propst TL; Faulkner BC; Vollmuth TA; Murray FJ
Food Chem Toxicol; 1998 Jul; 36(7):591-600. PubMed ID: 9687966
[TBL] [Abstract][Full Text] [Related]
12. Optimization of an exogenous metabolic activation system for FETAX. II. Preliminary evaluation.
Fort DJ; Rogers RL; Paul RR; Stover EL; Finch RA
Drug Chem Toxicol; 2001 May; 24(2):117-27. PubMed ID: 11360430
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Teratogenicity of Pharmaceuticals Using FETAX.
Islas-Flores H; Pérez-Alvaréz I; Gómez-Oliván LM
Methods Mol Biol; 2018; 1797():299-307. PubMed ID: 29896699
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Xenopus tropicalis as an alternative test organism for frog embryo teratogenesis assay--Xenopus (FETAX).
Song MO; Fort DJ; McLaughlin DL; Rogers RL; Thomas JH; Buzzard BO; Noll AM; Myers NK
Drug Chem Toxicol; 2003 Aug; 26(3):177-89. PubMed ID: 12953658
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the developmental toxicity of five compounds with the frog embryo teratogenesis assay: Xenopus (FETAX) and a metabolic activation system.
Fort DJ; James BL; Bantle JA
J Appl Toxicol; 1989 Dec; 9(6):377-88. PubMed ID: 2613998
[TBL] [Abstract][Full Text] [Related]
16. Phase III interlaboratory study of FETAX. Part 3. FETAX validation using 12 compounds with and without an exogenous metabolic activation system.
Bantle JA; Finch RA; Fort DJ; Stover EL; Hull M; Kumsher-King M; Gaudet-Hull AM
J Appl Toxicol; 1999; 19(6):447-72. PubMed ID: 10547627
[TBL] [Abstract][Full Text] [Related]
17. FETAX Assay for Evaluation of Developmental Toxicity.
Mouche I; Malésic L; Gillardeaux O
Methods Mol Biol; 2017; 1641():311-324. PubMed ID: 28748472
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the toxicity and teratogenity of six commercial textile dyes using the frog embryo teratogenesis assay-Xenopus.
Birhanli A; Ozmen M
Drug Chem Toxicol; 2005; 28(1):51-65. PubMed ID: 15720035
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of acetaminophen-induced developmental toxicity using FETAX.
Fort DJ; Rayburn JR; Bantle JA
Drug Chem Toxicol; 1992; 15(4):329-50. PubMed ID: 1459044
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the developmental toxicity of nicotine and cotinine with frog embryo teratogenesis assay: Xenopus.
Dawson DA; Fort DJ; Smith GJ; Newell DL; Bantle JA
Teratog Carcinog Mutagen; 1988; 8(6):329-38. PubMed ID: 2905544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
